$12.14 -0.15 (-1.22%)

BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

🚫 BridgeBio Oncology Therapeutics, Inc. Common Stock does not pay dividends

Company News

BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)
GlobeNewswire Inc. • Bridgebio Oncology Therapeutics • October 30, 2025

BridgeBio Oncology Therapeutics announced two poster presentations for BBO-10203, a novel small molecule targeting RAS and PI3Kα interactions in cancer treatment, at the San Antonio Breast Cancer Symposium in December 2025.